Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GILBERT LEDESMA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1720045842
CMS profile
260016
Location
ARLINGTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$6,472.76

210 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 5; records 101–150 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GILBERT LEDESMA

NPI 1720045842 · CMS profile ID 260016

Allopathic & Osteopathic Physicians / Family Medicine

ARLINGTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1720045842?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GILBERT LEDESMA, NPI 1720045842, CMS profile ID 260016. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1720045842?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). GILBERT LEDESMA, NPI 1720045842, CMS profile ID 260016. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1720045842?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
GILBERT LEDESMA, NPI 1720045842, CMS profile ID 260016, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1720045842?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

210 matching records · $6,472.76 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 210 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 210.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme Corporation $13.7307/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848529845 CMS
AbbVie Inc. $16.3107/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262055 CMS
AbbVie Inc. $15.9007/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262049 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.7407/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763784930 CMS
Novo Nordisk Inc $10.1507/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811378965 CMS
Janssen Pharmaceuticals, Inc $13.9506/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788604825 CMS
AbbVie Inc. $2.8906/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262043 CMS
Lilly USA, LLC $9.3506/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819078485 CMS
AbbVie Inc. $2.7706/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262037 CMS
Novo Nordisk Inc $9.7406/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811653921 CMS
Novo Nordisk Inc $32.2706/25/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810851011 CMS
Novo Nordisk Inc $32.2706/25/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810851017 CMS
AbbVie Inc. $9.9706/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262031 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.7706/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763784932 CMS
GlaxoSmithKline, LLC. $11.7006/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802027999 CMS
Lilly USA, LLC $5.0506/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819094305 CMS
Merck Sharp & Dohme Corporation $18.5206/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848571169 CMS
AbbVie Inc. $17.2206/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262025 CMS
Biohaven Pharmaceuticals, Inc. $18.4106/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852547477 CMS
AstraZeneca Pharmaceuticals LP $11.1406/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834343769 CMS
UPSHER-SMITH LABORATORIES LLC $14.9906/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834690075 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $10.3306/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763784934 CMS
Kowa Pharmaceuticals America, Inc. $12.6106/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 805516199 CMS
Novo Nordisk Inc $6.5306/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811233447 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.7306/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763784936 CMS
AbbVie Inc. $9.2105/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262019 CMS
Supernus Pharmaceuticals, Inc. $24.9505/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845069479 CMS
Novo Nordisk Inc $5.6005/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810851007 CMS
Amgen Inc. $16.6105/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825332393 CMS
Merck Sharp & Dohme Corporation $11.5405/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848403661 CMS
ASCEND Therapeutics US, LLC $16.3205/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828479959 CMS
Currax Pharmaceuticals LLC $11.2205/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792532689 CMS
Abbott Laboratories $12.8605/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815491041 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.4505/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763784938 CMS
AstraZeneca Pharmaceuticals LP $12.5705/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834331073 CMS
AbbVie Inc. $15.3505/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262013 CMS
GlaxoSmithKline, LLC. $14.2005/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802842503 CMS
Biohaven Pharmaceuticals, Inc. $15.3005/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852547475 CMS
Daiichi Sankyo Inc. $22.6605/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836292271 CMS
GlaxoSmithKline, LLC. $11.5005/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802961357 CMS
Novo Nordisk Inc $7.1905/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811525293 CMS
Lilly USA, LLC $20.9105/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819175343 CMS
AbbVie Inc. $14.2405/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262007 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.4504/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820041767 CMS
Daiichi Sankyo Inc. $19.4604/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836285981 CMS
Lilly USA, LLC $13.7304/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819078481 CMS
Biohaven Pharmaceuticals, Inc. $12.7304/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852547473 CMS
AbbVie Inc. $9.3004/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795262001 CMS
Merck Sharp & Dohme Corporation $18.7304/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848401805 CMS
Janssen Pharmaceuticals, Inc $14.7104/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788604819 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17,817.32 181
PY2020 $6,896.51 145
PY2021 $6,472.76 210
PY2022 $2,851.85 75
PY2023 $164.33 5
PY2024 $100.66 3
PY2025 $88.03 4

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $56,782.36 16
PY2024 Principal investigator $54,370.77 143
PY2023 Principal investigator $127,559.08 157
PY2022 Principal investigator $178,925.86 392
PY2021 Principal investigator $179,842.28 197
PY2020 Principal investigator $205,250.88 207
PY2019 Recipient $824.59 7
PY2019 Principal investigator $342,932.23 128

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

16 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alnylam Pharmaceuticals Inc. $6,000.00 11/19/2025 Non-covered Recipient Entity
Arlington Family Research Center, Inc.
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508711
Principal investigator 1 Alnylam Pharmaceuticals Inc. $2,598.00 11/19/2025 Non-covered Recipient Entity
Arlington Family Research Center, Inc.
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508715
Principal investigator 1 Novo Nordisk AS $687.50 10/29/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213737251
Principal investigator 1 Novo Nordisk AS $600.00 10/29/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213743034
Principal investigator 1 Novo Nordisk AS $150.00 10/29/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213744971
Principal investigator 1 Novo Nordisk AS $2,000.00 09/17/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213708329
Principal investigator 1 Novo Nordisk AS $750.00 09/17/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213730044
Principal investigator 1 Novo Nordisk AS $2,589.63 07/21/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213750723
Principal investigator 1 Novo Nordisk AS $23,167.54 03/31/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
EX9924-4473 No dispute reported 06/30/2026 1213745282
Principal investigator 1 Novo Nordisk AS $1,123.57 03/31/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213840646
Principal investigator 1 Novo Nordisk AS $6,050.00 03/28/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
EX9924-4473 No dispute reported 06/30/2026 1213774677
Principal investigator 1 Novo Nordisk AS $4,650.00 02/21/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
EX9924-4473 No dispute reported 06/30/2026 1213726477
Principal investigator 1 Novo Nordisk AS $1,393.94 02/21/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213783845
Principal investigator 1 Novo Nordisk AS $1,050.00 01/31/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
EX9924-4473 No dispute reported 06/30/2026 1213718130
Principal investigator 1 Novo Nordisk AS $2,500.00 01/31/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
EX9924-4473 No dispute reported 06/30/2026 1213719190
Principal investigator 1 Novo Nordisk AS $1,472.18 01/31/2025 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC
NN9535-4801 No dispute reported 06/30/2026 1213798187